- Supported exchanges /
- AU /
- IXC.AU
Invex Therapeutics Ltd (IXC AU) stock market data APIs
Invex Therapeutics Ltd, a biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia. It is involved in developing Exenatide, a treatment for neurological conditions derived from or involving raised intracranial pressure, such as idiopathic intracranial hypertension, acute stroke, and traumatic brain injury that has completed Phase III clinical trial. The company was incorporated in 2019 and is based in Perth, Australia.
Invex Therapeutics Ltd Financial Data Overview
| 0.075 | |
| 0.075 | |
| - | |
| 0.075 | |
| 0.075 | |
| 0.06-0.34 | |
| 5 637 K | |
| 75 154 K | |
| 1 212 K | |
| 2.484 | |
| 0.467 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Invex Therapeutics Ltd Fundamental Data is available in our Financial Data APIs
- Net Revenue 1 212 K
- EBITDA 0
- Earnings Per Share -0.02
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Invex Therapeutics Ltd Earnings via APIs
- Latest Release 2024-08-22
- EPS/Forecast NaN
Get Invex Therapeutics Ltd End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
